PHEBRA POTASSIUM PHOSPHATE CONCENTRATED Injection

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

monobasic potassium phosphate, Quantity: 109.33 mg/mL; dibasic potassium phosphate, Quantity: 105.33 mg/mL

Beschikbaar vanaf:

Phebra Pty Ltd

farmaceutische vorm:

Injection, intravenous infusion

Samenstelling:

Excipient Ingredients: water for injections

Toedieningsweg:

Intravenous

Eenheden in pakket:

10mL x 10

Prescription-type:

Not scheduled. Not considered by committee

therapeutische indicaties:

INDICATIONS AS AT 01 JANUARY 1991 : Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalemia. IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.

Product samenvatting:

Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Autorisatie-status:

Registered

Autorisatie datum:

1991-10-14